Previous close | 0.3989 |
Open | 0.4010 |
Bid | 0.3911 x 1000 |
Ask | 0.4099 x 1800 |
Day's range | 0.3900 - 0.4150 |
52-week range | 0.3850 - 2.5800 |
Volume | |
Avg. volume | 118,062 |
Market cap | 4.347M |
Beta (5Y monthly) | -1.77 |
PE ratio (TTM) | 0.59 |
EPS (TTM) | 0.6600 |
Earnings date | 11 Sept 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 7.75 |
XI’AN, China, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced its half-year financial results for the six months ended March 31, 2023. 1H-2023 Financial Highlights Revenue - Total revenues were $14.1 million, representing a 3.4% increase from US$13.7 million for the same period in 2022.Income from operation – for the six mo
XI’AN, China, July 07, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that the Company received a letter (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on June 30, 2023, due to the resignations of Messrs. James Edward Burns, Lawrence W. Leighton, and Jeffrey J. Guzy from the Company’s Board of Directors and
XI'AN, China, June 21, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on June 12, 2023, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for conti